Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity

Authors :: Agnieszka Blachnio-Zabielska
Eric Hajduch
Hervé Le Stunff
Epidemiology and Metabolic Disorders Department [Medical University of Bialystok]
Medical University of Białystok (MUB)
Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138))
École pratique des hautes études (EPHE)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)
Institut des Neurosciences Paris-Saclay (NeuroPSI)
Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)
Gestionnaire, Hal Sorbonne Université
Source :: Frontiers in Endocrinology, Frontiers in Endocrinology, 2022, 12, pp.835751. ⟨10.3389/fendo.2021.835751⟩, Frontiers in Endocrinology, Vol 12 (2022)
Publication Year :: 2022
Publisher :: Frontiers Media SA, 2022.
Abstract: International audience

Subjects :: [SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
ceramides
Endocrinology, Diabetes and Metabolism
sphingosine-1-phosphate
ApoM
biomarkers
type 2 diabetes
lipotoxicity
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
RC648-665
Diseases of the endocrine glands. Clinical endocrinology
ComputingMilieux_MISCELLANEOUS

Tools